Based on the significant clinical prevalence of SPHK1 in bladder cancer progression and the functional role of SPHK1 in cell migration, invasion, and metastasis, we further explore the potential targeted therapeutic regimen of SPHK1 using clinically relevant xenograft model. The gene discussed is SPHK1; the disease is urinary bladder carcinoma.